1-15 of 114

Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
CME/CE In-Person EventAdvancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
December 10, 2026
Durham, North Carolina

Elevating Adult SMA Care: Applying Real-World Evidence Through Case-Based Insights
CME/CEElevating Adult SMA Care: Applying Real-World Evidence Through Case-Based Insights

Secondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk
CME/CE Broadcast ReplaySecondary Stroke Prevention in Focus: Addressing Residual Thrombotic Risk

Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CEStarting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease

Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy

LGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
CME/CELGMD in Focus: Early Diagnosis, Precision Subtyping, and Targeted Therapies
- advertisement

Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CEEngineering Safer Antithrombotic Strategies for Secondary Stroke Prevention

When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
CME/CE Broadcast ReplayWhen “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease

Stroke-Like Symptoms During Treatment: Safety First
MinuteCE®Stroke-Like Symptoms During Treatment: Safety First

Talking Through Benefits, Risks, and Patient Priorities
MinuteCE®Talking Through Benefits, Risks, and Patient Priorities

Borderline Biomarkers: When a Blood Test Is Not Enough
MinuteCE®Borderline Biomarkers: When a Blood Test Is Not Enough

Antithrombotics and Amyloid Therapy: Balancing Risk
MinuteCE®Antithrombotics and Amyloid Therapy: Balancing Risk
- advertisement








































